Correlation Between Capital Clean and Catalyst Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Capital Clean and Catalyst Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Capital Clean and Catalyst Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Capital Clean Energy and Catalyst Pharmaceuticals, you can compare the effects of market volatilities on Capital Clean and Catalyst Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Capital Clean with a short position of Catalyst Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Capital Clean and Catalyst Pharmaceuticals.
Diversification Opportunities for Capital Clean and Catalyst Pharmaceuticals
0.36 | Correlation Coefficient |
Weak diversification
The 3 months correlation between Capital and Catalyst is 0.36. Overlapping area represents the amount of risk that can be diversified away by holding Capital Clean Energy and Catalyst Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Catalyst Pharmaceuticals and Capital Clean is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Capital Clean Energy are associated (or correlated) with Catalyst Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Catalyst Pharmaceuticals has no effect on the direction of Capital Clean i.e., Capital Clean and Catalyst Pharmaceuticals go up and down completely randomly.
Pair Corralation between Capital Clean and Catalyst Pharmaceuticals
Given the investment horizon of 90 days Capital Clean is expected to generate 1.3 times less return on investment than Catalyst Pharmaceuticals. But when comparing it to its historical volatility, Capital Clean Energy is 1.29 times less risky than Catalyst Pharmaceuticals. It trades about 0.07 of its potential returns per unit of risk. Catalyst Pharmaceuticals is currently generating about 0.07 of returns per unit of risk over similar time horizon. If you would invest 1,506 in Catalyst Pharmaceuticals on August 29, 2024 and sell it today you would earn a total of 687.00 from holding Catalyst Pharmaceuticals or generate 45.62% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Very Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Capital Clean Energy vs. Catalyst Pharmaceuticals
Performance |
Timeline |
Capital Clean Energy |
Catalyst Pharmaceuticals |
Capital Clean and Catalyst Pharmaceuticals Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Capital Clean and Catalyst Pharmaceuticals
The main advantage of trading using opposite Capital Clean and Catalyst Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Capital Clean position performs unexpectedly, Catalyst Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Catalyst Pharmaceuticals will offset losses from the drop in Catalyst Pharmaceuticals' long position.Capital Clean vs. RadNet Inc | Capital Clean vs. MACOM Technology Solutions | Capital Clean vs. Elmos Semiconductor SE | Capital Clean vs. Lipocine |
Catalyst Pharmaceuticals vs. Day One Biopharmaceuticals | Catalyst Pharmaceuticals vs. Terns Pharmaceuticals | Catalyst Pharmaceuticals vs. X4 Pharmaceuticals | Catalyst Pharmaceuticals vs. Inozyme Pharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.
Other Complementary Tools
Commodity Directory Find actively traded commodities issued by global exchanges | |
Share Portfolio Track or share privately all of your investments from the convenience of any device | |
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
Technical Analysis Check basic technical indicators and analysis based on most latest market data |